News on Pfizer (Ticker: PFE) continually updated from thousands of sources around the net.
3 hrs ago | Insider Monkey
Ranjith Gopinathan, who is a program manager, life sciences and healthcare practice at Frost & Sullivan during an interview on CNBC said that while Merck & Co., Inc. has to go for some kind of acquisition to strengthen its pipeline and because of that, I think, Pfizer Inc. in May, when the latter turned down its $118 billion bid offer.
7 hrs ago | Business Journal
Acclerator Corp., a Seattle a life-science investment firm that focuses on biotech businesses, said it's raised $51.1 million in capital funding, and will expand to New York City.
8 hrs ago | TheStreet.com
Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.
9 hrs ago | Business Journal
Helping reverse a nationwide trend of fewer female venture capitalists in recent years, Polaris Partners has named the only female partner currently at any of the area's top VC firms.
9 hrs ago | Newsday
United Parcel Service driver Marty Thompson starts his truck up after making a delivery in Cumming, Ga.
9 hrs ago | PE Hub
Polaris Partners , which is in the market for a $400 million seventh fund, has brought on board a noted healthcare general counsel.
10 hrs ago | Vallejo Times-Herald
Pfizer's second-quarter earnings plunged 79 percent from last year, when the world's second-largest drugmaker booked a business spinoff gain of more than $10 billion, but results in the most recent quarter still edged analyst expectations.
10 hrs ago | WTHR-TV Indianapolis
Most of the 1,200 people driven to evacuate by a Northern California wildfire that destroyed 13 homes have been told they can safely return after a series of steady gains in the firefight.
10 hrs ago | Customer Interaction Solutions
Pfizer Inc. reported financial results for second-quarter 2014. At the beginning of fiscal year 2014, the company began managing its commercial operations through a new global commercial structure consisting of three operating segments: the Global Innovative Pharmaceutical segment ; the Global Vaccines, Oncology and Consumer Healthcare segment ; ... (more)
11 hrs ago | The Globe and Mail
The Pfizer logo on the exterior of a former Pfizer factory, in the Brooklyn borough of New York, on May 4, 2014.
The East Side towers of the Alexandria Center for Life Science have attracted giant pharmaceutical companies such as Pfizer Inc. and Eli Lilly & Co.
When Provectus Biopharmaceuticals Inc. announced at the end of May that the FDA had denied it Breakthrough Therapy Designation it caused a sharp drop in the stock price.
Pfizer has a 59% positive surprise history . The overall average post earnings price move is 'positive' when the company reports earnings.
So concludes BMO Capital Markets today in a downgrade report, which sent shares of Pfizer down nearly 1% to $29.86.
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Inc .
Separately, TheStreet Ratings team rates PFIZER INC as a "buy" with a ratings score of B. TheStreet Ratings Team has this to say about their recommendation: "We rate PFIZER INC a BUY.
Pfizer Inc's vulnerability to cheaper generics and its weak roster of experimental medicines will be on display Tuesday when the company reports quarterly earnings, reviving interest in its pursuit of AstraZeneca Plc or other deals to fortify its pipeline.
Updated: Tue Jul 29, 2014 01:01 pm
Copyright © 2014 Topix LLC